Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis
Debra Van Egeren(Stanford University), Kevin M. Haigis(Harvard University), Allison M. Morgan(Children's Hospital of Philadelphia), Karen Pinilla(Cancer Research UK Cambridge Center), Mark Welsh(Children's Hospital of Philadelphia), Jocelyn Lee(American Association For Cancer Research), Matthew D. Ducar(Brigham and Women's Hospital), Yuankun Zhu(University of Shanghai for Science and Technology), Ron Beaudoin(Dana-Farber Cancer Institute), Jose‐Ezequiel Martín(University of Cambridge), Jean Abraham, Margaret Foti, Michele L. Lenoue-Newton(Vanderbilt University Medical Center), Khushi Kohli(Harvard University), Stephen‐John Sammut(Cambridge University Hospitals NHS Foundation Trust), Dilrini De Silva, Gary J. Doherty(Cambridge University Hospitals NHS Foundation Trust), Deepa Dand(Dana-Farber Cancer Institute), Philippe L. Bédard(Princess Margaret Cancer Centre), Michael V. Fiandalo(University of Kentucky), Jeremy L. Warner(Brown University), Alexander Gusev(Dana-Farber Cancer Institute), Jena Lilly(Children's Hospital of Philadelphia), Jennifer L. Mason(Children's Hospital of Philadelphia), Eva M. Lepisto, James D. Brenton(Cambridge University Hospitals NHS Foundation Trust), Bruce E. Johnson(Harvard University), Yekaterina B. Khotskaya(University of Alabama at Birmingham), Nicole Peters(American Association For Cancer Research), Allison P. Heath(Children's Hospital of Philadelphia), Shawn M. Sweeney(American Association For Cancer Research), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Kenneth L. Kehl(Dana-Farber Cancer Institute), William C. Hahn(Broad Institute), Roshni Biswas(Dana-Farber Cancer Institute), Paul J. Catalano(Computational Physics (United States)), Ethan Cerami, Yvonne Li(Broad Institute), Birgit Nimmervoll, Oya Cushing(Dana-Farber Cancer Institute), Marilyn M. Li(Children's Hospital of Philadelphia), Suzanne P. MacFarland(Children's Hospital of Philadelphia), Adam Resnick(Children's Hospital of Philadelphia), Deborah Schrag(Dana-Farber Brigham Cancer Center), Carlos Caldas(University of Cambridge), Lynette M. Sholl(Brigham and Women's Hospital), Franziska Michor(Dana-Farber Cancer Institute), Oscar M. Rueda(University of Cambridge), Ka–Jia Cao(Children's Hospital of Philadelphia), John M. Maris(Children's Hospital of Philadelphia)
Cited by 21
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k